Based on the aggregated intelligence of 170,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, phosphate producer Innophos Holdings (Nasdaq: IPHS) has earned a respected four-star ranking.

With that in mind, let's take a closer look at Innophos' business and see what CAPS investors are saying about the stock right now.

Innophos facts

Headquarters

Cranbury, N.J.

Market Cap

$752.3 million

Industry

Specialty chemicals

Trailing-12-Month Revenue

$669.3 million

Management

CEO Randolph Gress (since 2004)

CFO Neil Salmon (since 2009)

Return on Capital (Average, Past 3 Years)

20.1%

Cash/Debt

$54.9 million / $170 million

Dividend Yield

1.9%

Competitors

PotashCorp (NYSE: POT)

Mosaic (NYSE: MOS)

Agrium (NYSE: AGU)

Sources: Capital IQ (a division of Standard & Poor's) and Motley Fool CAPS.

On CAPS, 97% of the 860 members who have rated Innophos believe the stock will outperform the S&P 500 going forward. These bulls include aordinaryguy and thompsonac.

Less than two months ago, aordinaryguy tapped Innophos as an attractive way to make some income: "Industry leader, undervalued company at this price. Innophos is a great company by the numbers. Plus, it pays a dividend."

Innophos' position as one of the world's leading phosphate producers and its cheapish stock price continue to support its four-star status. Currently, Innophos even trades at a forward P/E (10.5) discount to much larger competitors PotashCorp (16.0), Mosaic (13.9), and Agrium (12.0), as well as other ag-sensitive plays like Dow Chemical (NYSE: DOW) (13.9) and DuPont (NYSE: DD) (14.1).

CAPS member thompsonac elaborates on the bargain opportunity:

[Innophos'] business in phosphates is important for cleaning products, soft drinks, etc. These are all staple products that aren't going anywhere. Plus, the company pays a nice dividend, which is a plus for buy-and-hold investors who are looking to benefit from a company willing to return profits to stock holders. This stock is a 'buy' at the current price of $32.75, and if the current sell-off takes [Innophos] down to the $30-level, I would call it a 'strong buy.'

What do you think about Innophos, or any other stock for that matter? If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future, and on Motley Fool CAPS, thousands of investors are working every day to find them. CAPS is 100% free, so get started!

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. The Fool owns shares of Innophos. Try any of our Foolish newsletter services free for 30 days.We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool's disclosure policy always gets a perfect score.